NEONC TECHNOLOGIES HOLDINGS, INC. Earnings Per Share (Basic)
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Earnings Per Share (Basic) of -$0.58 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.58.
- NEONC TECHNOLOGIES HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.38.
- NEONC TECHNOLOGIES HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.73.
- NEONC TECHNOLOGIES HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.45.
- NEONC TECHNOLOGIES HOLDINGS, INC. earnings per share, basic for fiscal 2025 was -$3.20.
- NEONC TECHNOLOGIES HOLDINGS, INC. earnings per share, basic for fiscal 2024 was -$0.69.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.58 10-Q · filed 2026-08-10 | -$0.96 10-Q · filed 2026-08-10 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2026-03-31 | -$0.38 10-Q · filed 2026-05-15 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.55 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.87 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-12-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.20 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$0.45 10-Q · filed 2025-11-14 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.48 10-Q · filed 2025-11-14 | -$2.65 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-06-30 | -$0.30 10-Q · filed 2026-08-10 | -$2.04 10-Q · filed 2026-08-10 | -$2.22 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.35 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-03-31 | -$1.78 10-Q · filed 2026-05-15 | -$2.10 10-Q · filed 2025-05-09 | -$1.95 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.07 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-05-15 |
| 2024-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.69 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$0.12 10-Q · filed 2025-11-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.56 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | -$0.27 10-Q · filed 2025-08-18 | -$0.45 10-Q · filed 2025-08-18 | |||
| 2024-03-31 | -$0.18 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |